Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
AJMB-Avicenna Journal of Medical Biotechnology. 2018; 10 (2): 62-68
in English | IMEMR | ID: emr-192946

ABSTRACT

Background: One of the most significant problems in the treatment of leukemia is the expansion of resistance to chemotherapeutic agents. Therefore, assessing the drug resistance and especially the drug resistance genes of leukemic cells is important in any treatment. The impact of Mesenchymal Stem Cells [MSCs] and hypoxic condition have been observed in the biological performance of majority of leukemic cells


Methods: MOLT-4 cells were co-cultured with MSCs in the hypoxic condition induced by Cobalt Chloride [CoCl2] for 6 and 24 hr. Then, apoptosis of cells was analyzed using annexin-V/PI staining and expression of the drug resistance genes including MDR1, MRP, and BCRP along with apoptotic and anti-apoptotic genes, including BAX and BCL2, was evaluated by real-time PCR


Results: The hypoxic condition for MOLT-4 cells co-cultured with MSCs could significantly increase the expression of MDR1 and BCRP genes [p<0.05] which are involved in drug resistance. Also, the results indicated that this condition significantly increases the expression of BCL2 [p<0.05] and reduces the apoptosis in MOLT- 4 cells co-cultured with MSCs in the hypoxic condition


Conclusions: These effects can demonstrate the important role of hypoxia and MSCs on the biological behavior of Acute Lymphoblastic Leukemia [ALL] cells that may lead to particular treatment outcomes

SELECTION OF CITATIONS
SEARCH DETAIL